Literature DB >> 27323967

EphA4-mediated signaling regulates the aggressive phenotype of irradiation survivor colorectal cancer cells.

Priscila Guimarães de Marcondes1, Lilian Gonçalves Bastos1, Julio Cesar Madureira de-Freitas-Junior1, Murilo Ramos Rocha1, José Andrés Morgado-Díaz2.   

Abstract

Radiotherapy is widely used for advanced rectal tumors. However, tumor recurrence after this treatment tends to be more aggressive and is associated with a poor prognosis. Uncovering the molecular mechanism that controls this recurrence is essential for developing new therapeutic applications. In the present study, we demonstrated that radiation increases the EphA4 activation level of the survivor progeny of colorectal cancer cells submitted to this treatment and that such activation promoted the internalization of a complex E-cadherin-EphA4, inducing cell-cell adhesion disruption. Moreover, EphA4 knockdown in the progeny of irradiated cells reduced the migratory and invasive potentials and metalloprotease activity induced by irradiation. Finally, we demonstrated that the cell migration and invasion potential were regulated by AKT and ERK1/2 signaling, with the ERK1/2 activity being dependent on EphA4. In summary, our study demonstrates that these signaling pathways could be responsible for the therapeutic failure, thereby promoting local invasion and metastasis in rectal cancer after radiotherapy. We also postulate that EphA4 is a potential therapeutic target for colorectal cancer treatment.

Entities:  

Keywords:  Colorectal cancer; E-cadherin; EphA4 receptor; Radiotherapy; Signaling pathways

Mesh:

Substances:

Year:  2016        PMID: 27323967     DOI: 10.1007/s13277-016-5120-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

Review 1.  Mechanisms and functions of Eph and ephrin signalling.

Authors:  Klas Kullander; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

Review 2.  Eph/ephrin signaling: networks.

Authors:  Dina Arvanitis; Alice Davy
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

3.  Progeny from irradiated colorectal cancer cells acquire an EMT-like phenotype and activate Wnt/β-catenin pathway.

Authors:  Lilian Gonçalves dos Reis Bastos; Priscila Guimarães de Marcondes; Julio Cesar Madureira de-Freitas-Junior; Fernanda Leve; André Luiz Mencalha; Waldemir Fernandes de Souza; Wallace Martins de Araujo; Marcelo Neves Tanaka; Eliana Saul Furquim Werneck Abdelhay; José Andrés Morgado-Díaz
Journal:  J Cell Biochem       Date:  2014-12       Impact factor: 4.429

4.  Frequent activation of the β-catenin gene in sporadic colorectal carcinomas: A mutational & expression analysis.

Authors:  Mumtaz Anwar; Rakesh Kochhar; Rajinder Singh; Alka Bhatia; Kim Vaiphei; Akhtar Mahmood; Safrun Mahmood
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

5.  EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.

Authors:  Megumi Iiizumi; Masayo Hosokawa; Akio Takehara; Suyoun Chung; Toru Nakamura; Toyomasa Katagiri; Hidetoshi Eguchi; Hiroaki Ohigashi; Osamu Ishikawa; Yusuke Nakamura; Hidewaki Nakagawa
Journal:  Cancer Sci       Date:  2006-09-05       Impact factor: 6.716

6.  MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells.

Authors:  Yan Yan; Yue-Chen Luo; Hai-Ying Wan; Jun Wang; Pei-Pei Zhang; Min Liu; Xin Li; Shengping Li; Hua Tang
Journal:  Hepatology       Date:  2013-01-08       Impact factor: 17.425

Review 7.  EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.

Authors:  Reneé C Ireton; Jin Chen
Journal:  Curr Cancer Drug Targets       Date:  2005-05       Impact factor: 3.428

8.  Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?

Authors:  Frank A Vicini; Larry Kestin; Raywin Huang; Alvaro Martinez
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

9.  EphA receptors regulate prostate cancer cell dissemination through Vav2-RhoA mediated cell-cell repulsion.

Authors:  Jennifer Batson; Lucy Maccarthy-Morrogh; Amy Archer; Helen Tanton; Catherine D Nobes
Journal:  Biol Open       Date:  2014-05-02       Impact factor: 2.422

10.  A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.

Authors:  Aaron Petty; Eugene Myshkin; Haina Qin; Hong Guo; Hui Miao; Gregory P Tochtrop; Jer-Tsong Hsieh; Phillip Page; Lili Liu; Daniel J Lindner; Chayan Acharya; Alexander D MacKerell; Eckhard Ficker; Jianxing Song; Bingcheng Wang
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more
  8 in total

1.  FLYWCH1, a Novel Suppressor of Nuclear β-Catenin, Regulates Migration and Morphology in Colorectal Cancer.

Authors:  Belal A Muhammad; Sheema Almozyan; Roya Babaei-Jadidi; Emenike K Onyido; Anas Saadeddin; Seyed Hossein Kashfi; Bradley Spencer-Dene; Mohammad Ilyas; Anbarasu Lourdusamy; Axel Behrens; Abdolrahman S Nateri
Journal:  Mol Cancer Res       Date:  2018-08-10       Impact factor: 5.852

2.  High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer.

Authors:  Ching-Yih Lin; Ying-En Lee; Yu-Feng Tian; Ding-Ping Sun; Ming-Jen Sheu; Chen-Yi Lin; Chien-Feng Li; Sung-Wei Lee; Li-Ching Lin; I-Wei Chang; Chieh-Tien Wang; Hong-Lin He
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

3.  Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-ß induced epithelial mesenchymal transition via Src/ANXA2/STAT3.

Authors:  Murilo R Rocha; Pedro Barcellos-de-Souza; Annie Cristhine M Sousa-Squiavinato; Priscila V Fernandes; Ivanir M de Oliveira; Mariana Boroni; Jose A Morgado-Diaz
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

4.  Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells.

Authors:  Erika López-Arribillaga; Verónica Rodilla; Carlota Colomer; Anna Vert; Amy Shelton; Jason H Cheng; Bing Yan; Abel Gonzalez-Perez; Melissa R Junttila; Mar Iglesias; Ferran Torres; Joan Albanell; Alberto Villanueva; Anna Bigas; Christian W Siebel; LLuís Espinosa
Journal:  Nat Commun       Date:  2018-07-31       Impact factor: 14.919

5.  EphA4-ADAM10 Interplay Patterns the Cochlear Sensory Epithelium through Local Disruption of Adherens Junctions.

Authors:  Jean Defourny; Christiane Peuckert; Klas Kullander; Brigitte Malgrange
Journal:  iScience       Date:  2018-12-26

6.  Ephrin Receptor A4 is a New Kaposi's Sarcoma-Associated Herpesvirus Virus Entry Receptor.

Authors:  Jia Chen; Xianming Zhang; Samantha Schaller; Theodore S Jardetzky; Richard Longnecker
Journal:  mBio       Date:  2019-02-19       Impact factor: 7.867

7.  LINC00152 is a potential biomarker involved in the modulation of biological characteristics of residual colorectal cancer cells following chemoradiotherapy.

Authors:  Zhengting Chen; Xinyi Cai; Li Chang; Yaoxiong Xia; Li Wang; Yu Hou; Lan Li; Dingguo Pan; Furong Li; Shan Liu; Wei Xiong; Wenhui Li
Journal:  Oncol Lett       Date:  2018-01-22       Impact factor: 2.967

8.  Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches.

Authors:  Christos Masaoutis; Natalia Georgantzoglou; Panagiotis Sarantis; Irene Theochari; Nikolaos Tsoukalas; Mattheos Bobos; Paraskevi Alexandrou; Alexandros Pergaris; Dimitra Rontogianni; Stamatios Theocharis
Journal:  Diagnostics (Basel)       Date:  2021-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.